Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Antigenic telomerase-derived proteins/peptides for cancer

March 6, 2000

Antitumor immunity induced by elemene involves enhancement of HSP70 expression

March 2, 2000

GVAX lung cancer vaccine advances to multicenter phase I/II trials

March 1, 2000

Monoclonal antibody targeting Lewis X combined with chemotherapy in breast cancer

Feb. 29, 2000

Second orphan drug designation granted for Maxamine

Feb. 25, 2000

Phase III data presented for Corixa's melanoma vaccine

Feb. 22, 2000

Results of phase II Multikine cancer study promising

Feb. 22, 2000

Aventis and MediGene to codevelop melanoma vaccine

Feb. 21, 2000

Campath BLA accepted for filing

Feb. 17, 2000

NCI extends two CRADAs with Therion Biologics for cancer vaccines

Feb. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...